An immunological approach to acute myeloid leukaemia

Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)
B GonzálezA Pérez-Martínez

Abstract

Acute myeloid leukaemia (AML) is the second haematological malignancy in the paediatric population, and one of the leading causes of childhood cancer mortality. Survival is currently around 60%, with no improvement in last decades, suggesting that new therapeutic approaches are needed. The anti-leukaemia effect mediated by the lymphocytes and natural killer (NK) cells of the immune system has been established in haematopoietic stem cell transplantation, and also as adoptive immunotherapy after consolidation chemotherapy schemes. A retrospective study was conducted on the clinical characteristics of patients diagnosed and treated for AML in our centre during 1996-2014. The mean fluorescence intensities of HLA-I, MICA/B and ULBP1-4, ligands for NK cell receptors, were also analysed in ten new diagnosed leukaemia cases, five myeloid and five lymphoid. A total of 67 patients were used in this analysis. With a median follow up of 25 months, the event-free survival was 62% (95% CI: 55-67). Secondary AML, non-M3 phenotype, and the absence of favourable cytogenetic markers had a lower survival. The probability of relapse was 38% (95% CI: 31-45). The expression of HLA-I and ULBP-4 was significantly lower in myeloid than in lymphoid blas...Continue Reading

References

Feb 5, 2008·Current Stem Cell Research & Therapy·Marc BieringsC Michel Zwaan
Jan 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey E RubnitzWing Leung
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ching-Hon PuiRobert J Arceci
Aug 27, 2011·Mediterranean Journal of Hematology and Infectious Diseases·Richard A Larson, Michelle M Le Beau
Mar 1, 2012·Expert Review of Anticancer Therapy·Gertjan J L Kaspers
May 9, 2012·Blood·Jeffrey E Rubnitz
Jun 26, 2012·Blood·Henrik HasleUNKNOWN Nordic Society of Paediatric Haematology and Oncology (NOPHO)
Aug 14, 2012·American Journal of Hematology·Jelena D MilosevicRobert Kralovics
May 9, 2013·Annals of the New York Academy of Sciences·Matthew D Vesely, Robert D Schreiber
Jun 14, 2013·Pediatric Hematology and Oncology·Claudia BrehmPeter Bader
Jun 27, 2013·Blood·Scott R DaigleRoy M Pollock
Oct 26, 2013·Paediatric Drugs·Jennifer DavilaThomas Renaud
Mar 13, 2014·Seminars in Immunology·Franco LocatelliPietro Merli
Mar 29, 2014·Frontiers in Oncology·Sarah K TasianRichard Aplenc
Jun 8, 2014·Best Practice & Research. Clinical Haematology·Francesco Lo-Coco, Syed Khizer Hasan
Sep 17, 2014·Current Opinion in Oncology·Raul C Ribeiro
Oct 18, 2014·International Archives of Allergy and Immunology·Lorenzo MorettaMaria Cristina Mingari
Dec 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paresh VyasCharles Craddock
Jun 27, 2015·Seminars in Hematology·Christopher G KanakryLeo Luznik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.